https://investor.ironwoodpharma.com/press-releases/press-release-details/2020/Ironwood-Pharmaceuticals-Reports-Second-Quarter-2020-Results-Delivered-GAAP-Net-Income-of-25-Million-and-Adjusted-EBITDA-of-33-Million/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- August 6, 2020